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Abstract: Prion diseases (e.g. ‘mad cow’ disease in cattle, chronic wasting disease in
deer and elk, Creutzfeldt-Jakob disease in humans) have been a major public health con-
cern affecting humans and almost all animals. However, dogs are strongly resistant to
prion diseases. Recently, through transgenic techniques, it was reported that the single
(surface) residue D159 is sufficient to confer protection against protein conformational
change and pathogenesis, thus provides conformational stability for dog prion protein
(Neurobiology of Disease 95 (November 2016) 204-209). This paper studies dog prion
protein wild-type and D159N mutant through molecular dynamics (MD) techniques.
Our MD results reveal sufficient structural informatics on the residue at position 159
to understand the mechanism underlying the resistance to prion diseases of dogs.
Key words: prion diseases; immunity of dogs; key residue D159; wild-type and mu-
tant; molecular dynamics.
1 Introduction
Unlike bacteria and viruses, which are based on DNA and RNA, prions are unique
as disease-causing agents since they are misfolded proteins. Prions propagate by de-
forming harmless, correctly folded proteins into copies of themselves. The misfolding
is irreversible. Prions attack the nervous system of the organism, causing an incurable,
fatal deterioration of the brain and nervous system until death occurs. Some examples
of these diseases are ‘mad cow’ disease (BSE) in cattle, chronic wasting disease (CWD)
in deer and elk, and Creutzfeldt-Jakob disease (CJD) in humans.
Not every species is affected by prion disease. Rabbits, water buffalo, horses, and
dogs are resistant to prion diseases [22]. The research question arises: What are rea-
sons allowing the protein of a resistant species to retain its folding? For rabbit normal
cellular prion protein (PrPC, where the structural region of a PrPC consists of β-strand
1 (β1), α-helix 1 (α1 or H1), β-strand 2 (β2), α-helix 2 (α2 or H2), α-helix 3 (α3 or
H3), and the loops linking them each other), multiple amino acid residues G99, M108,
S173, I214, together inhibit formation of its abnormal isoform [17]. For dog PrP, D159
is the key protective residue that provides conformational stability and confers protec-
tion against prions, suggesting that a single amino acid D159 is sufficient to prevent
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PrP conformational change and pathogenesis [15]. This paper will specially study the
residue D159 of dog PrP from the protein structural dynamics point of view.
First, let us review some known literatures on dog PrP (and we particularly focus
on its structural bioinformatics). There are a lot of literatures reporting dogs (and
other canines) are rare animals being resistant to prion diseases, for examples [2, 3, 5,
6, 11, 13, 14, 16, 19, 24].
− Early in 1994, it was found that not a single case of prion disease has been
described among dogs through the exposure of dogs to prions (being fed prion-
infected pet food) [6].
− In 1999, it was reported that two differences between feline and canine PrP se-
quences, at codons 187 and 229, both involve substitutions to Arg residues which,
together with the His-Arg substitution at codon 177 common to cat and dog,
would increase the total positive surface charge on the molecule - this might
in turn affect the potential intermolecular interactions critical for cross-species
transmission of prion disease [19].
− In 2004, it was reported that the three substitutions in positions 108, 164, and 182
are unique to the canine species and are thus candidates for causing a substantial
species barrier, and dogs are among the few mammals that neither contain Asn
at position 164 (or 159) nor His at position 182 (or 177) [8, 9].
− In 2005, the NMR structure of dog PrP was released (PDB entry 1XYK) and
it was reported that the residues at positions 159 and 177 have unique charge
distribution patterns on the front as well as the back side of dog PrPC [10]. The
residue D159 (less defined by NMR) is proposed to change the surface charge [10]
due to its sticking out acidic side chain.
− In 2006, the open reading frame of the prion protein (Prnp) gene from 16 Pekingese
dogs was cloned and screened for polymorphisms [20]. One nucleotide polymor-
phism (G489C) was found; the G to C nucleotide substitution results in a glutamic
to aspartic acid change at codon 163; E/D163 and asparagine 107 in canine prion
protein genes were replaced by asparagine and serine, respectively, in all the prion
protein genes examined [20].
− In 2008, transmission experiments in Madin Darby canine kidney (MDCK) cells
showed they do not replicate human CJD prions and mouse (infected with scrapie)
prions [13], supporting the resistance of dogs to prions. Human PrPC is selectively
targeted to the apical side of the MDCK [1].
− In 2009, Onizuka (2009) reported the substitutions N104G and S107N have the
biggest impact to the conformational transition and stability of dog PrP [12]. In
2009, it was reported in [18] that the three substitutions in positions 107, 163,
and 181 are unique to the Arctic fox and dog, and these substitutes might be
associated with susceptibility and species barriers in prion diseases.
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− In 2010, Khan et al. (2010) found that at pH 4.0 dogs have the lowest concen-
tration of β intermediate state compared with hamsters, mice, rabbits and horses
[5, 14] - this can be adopted in evaluating the prion disease susceptibility of each
species (hamster>mouse>rabbit>horse>dog) [2, 5, 14].
− In 2013, Hasegawa et al. (2013) reported that there are large differences in local
structural stabilities between canine and bovine PrP, and this appearance might
link diversity in susceptibility to BSE prion infection [3].
− In 2015, a survey of prnp genes implied that the prion disease resistant canines
harbor amno acids DRK in positions 159, 177, and 185 [11]. Arg177 in H2 of dog
PrP also causes unique charge distribution patterns on the front and the back
side of dog PrPC [10], but Arg177 are positively charged residue that should have
minor effects on PrP structure and surface charge [15], because the sequence of
the rigid β2-α2 loop in the dog is identical to mouse PrP, indicating that this
region does not contribute to the conformational stability of dog PrP [2].
In 2016, Sanchez-Garcia et al. (2016) reported that a single amino acid (D159) from
the dog PrP suppresses the toxicity of the mouse PrP in Drosophila [15] and their
laboratory experience suggested that a single D159 substitution is sufficient to prevent
PrP conformational change and pathogenesis [15]. D159 is a unique amino acid found
in PrP from dogs and other canines that was shown to alter surface charge. The acidic
amino acid D159 is on the α1-β2 loop and exposed on the surface of dog PrP, resulting
in increased negative charge [15]. The β1-α1 and α1-β2 loops interact more closely
in dog PrP than in susceptible animals thus the subtle changes in the orientation of
the side chains and the closer loops may affecting the stability of the β-sheet [3, 10] -
this might explain the poor NMR resolution of residue D159. The mutation N159 will
create a neutral surface that extends over the surface of the two loops (i.e. the β1-α1
loop and the α1-β2 loop) and H2 [15]. In the D159 region there only harbors one non-
sense pathogenic mutation Q160X, however, this critical domain should be investigated
in more details, because the identification of α1-β2 loop-binding proteins are expected
to reveal clues about the molecular mechanisms and the extrinsic factors mediating
PrP conversion from soluble normal prion protein PrPC (predominant in α-helices) to
insoluble diseased infectious prions PrPSc (rich in β-sheets) [15]. It has been proposed
that this change in surface charge will result in altered interactions with other proteins,
possibly proteins that contribute to PrP conversion [15]. The α1-β2 loop is highly
conserved among mammals but only dog PrP possesses the unique acidic residue D159
suggesting that D159 plays a role in providing global stability to dog PrP [2]. We also
once reported that the residue at position 159 is unique in dog PrPC [21, 22, 23]. This
paper will continue our research on the molecular dynamics (MD) studies of dog PrP,
especially on the MD studies of its D159N mutant and their comparisons.
The rest of this paper is organized as follows. In Section 2 we will give the MD
simulation materials and methods. Section 3 will presents the MD results and their
analyses (where surface charge distributions are specially focused to analyze the MD
trajectories). After the Results and Discussions section, some Concluding Remarks
(revealed from the MD to understand the mechanism underlying the resistance to prion
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diseases of dogs) will be given in the last section of this paper.
2 Materials and Methods
The MD simulation materials and methods are completely as the ones of [21, 22, 23].
The D159N mutant model used in this study was constructed by one mutation D159N
at position 159 using the NMR structure 1XYK.pdb of dog PrP (121–231), where the
NMR experimental temperature is 293 K (i.e. the room temperature), pH value is 4.5,
and pressure is AMBIENT. To neutralize the MD systems by sodium ions, 2 Na+ ions
were added to the wild-type, and 1 Na+ ion was added to the D159N mutant (be-
cause the residue Asn is without charge). 1XYK.pdb has 8 Arg+ residues and 4 Lys+
residues (and 2 His+ residues), 6 Asp- residues and 8 Glu- residues, two salt bridges
D144.OD1–R+148.NH1/2, D178.OD2–R+164.NE/NH2 and one cation-pi interaction
R164.CD-Y128 detected by FirstGlance in Jmol (bioinformatics.org/firstglance/fgij/).
This paper uses Maestro 9.7 2014-1 (Academic use only) free package to draw the Pois-
sonBoltzmann electrostatic potential surface charges of the external polarization: we
choose indi = 1.0 as the solute dielectric constant, exdi = 80.0 as the solvent dielectric
constant, 12 A˚ as the solvent radius, and 300 K as the Temperature: EPS mapped on
molecular surface is chosen.
Electrostatic potential surfaces are valuable in structure-based/computer-aided drug
design because they help in optimization of electrostatic interactions between the pro-
tein and the ligand. These surfaces can be used to compare different inhibitors with
substrates or transition states of the reaction. To study the surface charge of a residue
and its local and global impacts should firstly consider the salt bridges (SBs) it linked
with [25]. SBs are calculated by oppositely charged atoms that are within 6.5 A˚ and are
not directly hydrogen-bonded. It should be the average charge calculated per residue or
the specific atom charge of the residue. The donor residues involved are Asp-, Glu-, and
the acceptor residues involved are Lys+, Arg+, His+, and the real computed distance
is within 6.5 A˚ in Amber package.
3 Results and Discussions
Firstly, we see the secondary structure changes of the D159N mutant and of the wild-
type during the whole 30 ns’ molecular movement. By Fig. 1, we may see what we
want: for β1 and β2, the wild-type has the clear extended β-strand (participates in
β-ladder) structure (with the occupied rate 3.66% during the whole 30 ns), but the
D159N mutant has changed into β-bridge structures (occupied rate 0.34% during 30
ns). This performance implied to us the mutation D159N has clearly changed the PrP
structure in domains of β1, the β1-α1 loop, H1, the α1-β2 loop, β2, and the β2-α2
loop. The mutation made the stable wild-type structure (before H2) become unstable.
Secondly, we see the SBs of the D159N mutant and of the wild-type during the 30
ns’ MD simulations. As we previously reported [21, 22, 23] the SB D178–R164 like a
taut bow string of the β2-α2 loop was broken by the D159N mutation (Fig. 2). This
implies to us that residue R164 spans only 4 residues from residue D159, and residue
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Figure 1: Secondary Structure graph for dog PrP D159N mutant and dog PrP wild-type (from
up to down) at 300 K under neutral pH environment (x-axis: time (030 ns), y-axis: residue
number; red: α-helix (H), blue: β-sheet (E), where H = α-helix, B = residue in isolated β-
bridge, E = extended strand, participates in β-ladder, G = 3-helix (310 helix), I = 5 helix
(pi-helix), T = hydrogen bonded turn, and S = bend).
D159 has a rather impact on the local structure. The SB D159–R136 at residue D159,
with occupied rate 92.48% during 30 ns, was broken in the D159N mutant; this SB
keeps the β1-α1 loop apart from the α1-β2 loop. This shows the stabilizing effect of
D159 in dog PrP to affect the both locally and globally unusual charge distribution
of NMR structure of dog PrP. Furthermore, we want to see and analyze all the SBs
during the whole 30 ns (Tab. 1). Seeing Table 1, we may know that “<” shows the local
impact of the D159N mutation which made the weaker of the wild-type’s SBs such as
D159–R+136, E211–R+177, D147–R+151, D178–R+164, E146–K+204, E196–R+156,
D202–R+156, H+187–R+156, E152–R+148, and “*” implies the global impact of the
D159N mutation which made weaker of the wild-type’s SBs. To understand better the
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Figure 2: The SB D178–R164 of the D159N mutant (with occupied rate 9.25% during the
whole 30 ns of MD) and of the wild-type (with occupied rate 49.43% during the whole 30 ns of
MD) at 300 K under neutral pH condition..
Table 1: All SBs of the D159N mutant and of the wild-type at 300 K, neutral pH value during
the whole 30 ns’ MD simulations:
Salt Bridges D159N mutant Wild-type In PrP,
(SBs) (% occupied rate) (% occupied rate) where?
D147–R+148 100.00 100.00 in H1
D178–R+177 99.82 99.57 in H2
E223–K+220 98.56 41.85 in H3
E207–K+204 98.43 96.13 in H3
E211–R+208 97.71 * 99.13 in H3
D144–R+148 93.72 53.47 in H1
D147–H+140 82.21 72.37 H1 – β1-α1-loop
E207–R+208 76.43 44.87 in H3
E196–K+194 75.98 59.57 in α2-α3-loop
E152–R+148 53.16 < 53.52 in H1
E152–R+151 51.11 43.63 in H1
H187–R+156 42.75 < 44.74 H2 – α1-β2-loop
E211–R+177 30.02 < 45.91 H3 – H2
E221–K+220 14.07 * 53.71 in H3
D147–R+151 11.41 < 25.68 in H1
D202–H+187 9.25 1.19 H3 – H2
D178–R+164 7.82 < 49.43 H2 – β2-α2-loop
D167–R+228 4.22 β2-α2-loop – H3
E146–K+204 2.96 < 24.73 H1 – H3
H187–K+185 2.31 0.46 in H2
E196–R+156 0.43 < 16.20 α2-α3-loop – α1-β2-loop
H140–R+151 0.20 * 0.29 β1-α1-loop – H1
E200–K+204 0.03 * 0.21 in H3
E196–H+187 0.03 * 0.09 α2-α3-loop – H2
E221–R+228 0.02 in H3
D159–R+136 < 92.48 α1-β2-loop – β1-α1-loop
D202–R+156 < 8.20 H3 – α1-β2-loop
E223–R+228 * 0.15 in H3
D144–H+140 * 0.05 in β1-α1-loop
H140–R+228 * 0.01 β1-α1-loop – H3
above SBs, we illuminate the surface charge distributions of the 30 ns’ average structure
of the D159N mutant and the wild-type respectively (Fig. 3). From Fig. 3, we see that
the D159N mutation made the negative charges and the positive charges redistributed
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Figure 3: Surface charge distributions of the 30 ns’ average structure. Left: The N159 mutant
of dog PrP; right: The wild-type of dog PrP. The circles indicate charge differences originating
at position 159. Red, blue, and white indicate the negative, positive charges and uncharged
respectively.
around the residue at position 159; however, the negative charges covering H1 and the
tail of H3 are not changed very much - this implies to us we had better not seek drug
target(s) from H1 or the tail of H3.
Thirdly, we will give a brief overview of the changes of some hydrogen bonds (HBs)
and hydrophobic interactions (HYDs) made by the D159N mutation. In view of the
number of HBs, we cannot say differences between the D159N mutant and the wild-
type; however, the HBs listed in Tab. 2 contribute to the structural stability of wild-
type dog PrP more than of the D159N mutant. We may see from Tabs. 1∼2 that
(i) D202–R+156 and E223–R+228 are two polar contacts for the wild-type, but the
D159N mutant is without these polar contacts; (ii) D147–H+140, E211–R+177, D147–
R+151, D178–R+164 are four strong polar contacts for the wild-type but weaker for the
D159N mutant. Regarding hydrophobic interactions (HYDs), throughout the whole 30
ns’ MD simulations, the D159N mutation has a local impact - it made HYD M213–V161
become weaker than in the wild-type, and has global impacts - it made V215–M213
and V209–I205 become weaker than in the wild-type. Around the residue at position
159, we find there are one pi-pi stacking F141–Y150 and one pi-cation Y164–R164 in
the D159N mutant and the pi-pi stacking F141–Y150 in the wild-type PrP through the
whole 30 ns’ protein movement. We also noticed that GN8 [7, 4], an antiprion drug
fixing the distance between N159 and E196 being 1.54 A˚, was designed at the position
159 - this might show the importance of the PrP residue at position 159.
4 Concluding Remarks
The mutation D159N of dog PrP had profound effects on protein structure of dog PrP:
(1) it altered the surface charge distribution, both locally and globally, (2) it reduced
the stability of the tertiary structure of dog PrP, and (3) it increased the mobility of dog
PrP structure before H2. The MD studies of this paper confirmed these three findings
and emphasized the contribution of the single residue D159 in dictating the global (and
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local) charge distribution and structural stability of dog PrP. This paper presented
detailed sufficient structural informatics on the residue at position 159 to understand
the mechanism underlying the resistance to prion diseases of dogs; this may be useful
for the medicinal treatment of prion diseases.
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Table 2: All HBs of the D159N mutant and of the wild-type at 300 K, under neutral pH
environment during the whole 30 ns’ MD simulations:
Hydrogen bonds D159N mutant Wild-type
(HBs) (% occupied rate) (% occupied rate)
T188@O–T192@HG1 89.69 90.84
C179@O–Y183@HG1 86.21 89.55
D178@OD1–R+164@HE 13.13 54.05
D178@OD2–R+164@HH21 9.18 52.07
D178@OD1–R+164@HH21 6.95 38.84
D202@OD2–R+156@HH21 46.46
D202@OD1–R+156@HH21 38.87
D202@OD1–R+156@HE 37.73
D202@OD2–R+156@HE 17.25
D202@OD1–Y157@HH 9.74 53.98
D202@OD2–T199@HG1 41.63
D202@OD1–T199@HG1 13.73
D202@OD2–Y149@HH 24.72
D202@OD1–Y149@HH 17.85
H+187@O–T191@HG1 71.25 84.35
Y149@O–N153@HD21 17.46
Q212@O–T216@HG1 48.43 81.55
Q227@OE1–Q212@HE21 13.29
Q212@OE1–Q227@HE21 9.74
D147@OD1–R+151@HH12 7.00 26.35
D147@OD1–R+151@HH11 6.75 24.47
D147@OD2–H+140@HD1 16.73 26.46
D144@OD1–R+151@HH12 11.39
V189@O–T193@HG1 21.28 32.71
E211@OE2–R+177@HH21 11.91 15.17
E211@OE1–R+177@HH21 8.41 18.94
E211@OE2–R+177@HE 29.98
E211@OE1–R+177@HE 26.05
E211@OE1–R+177@HH12 8.71
E207@OE2–R+177@HH22 6.55 10.69
E207@OE1–R+177@HH22 5.21 14.15
E207@OE1–R+177@HH12 6.57
E223@O–R+228@HH21 10.76
E223@O–R+228@HE 11.24
E223@O–R+228@HH11 7.45
E223@O–Q219@HE22 13.09
E146@OE2–K+204@HZ2 6.34 18.46
E146@OE2–K+204@HZ1 5.96 16.90
E146@OE1–K+204@HZ2 5.94 17.65
E146@OE2–K+204@HZ3 5.69 15.90
E146@OE1–K+204@HZ3 5.54 15.75
E146@OE1–K+204@HZ1 5.31 16.76
Q219@OE1–Q227@HE22 24.37
Q227@OE1–Q219@HE22 5.71
T216@OG1–Q227@HE21 6.78
S231@OG–N171@HD22 9.12
G229@O–N171@HD21 28.10
H+140@O–R+208@HH21 22.37
H+140@O–R+208@HE 11.59
P158@O–R+136@HH12 15.63
V176@O–Y218@HH 14.65
D178@OD1–Y128@HH 8.95
Q186@OE1–Y128@HH 8.62
S132@OG–Q217@HE21 7.61
N174@OD1–Q172@HE22 7.36
A224@O–R+228@HH11 6.95
Y225@O–R+228@HE 6.63
N197@O–R+156@HH22 6.33
E196@OE2–R+156@HH12 5.33
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